Cowen Starts Acadia Pharmaceuticals (ACAD) at Outperform
Tweet
Share
E-mailGet Alerts ACAD Hot Sheet
Price: $29.21 +2.67%
Rating Summary:
17 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 33 | Down: 45 | New: 4
Rating Summary:
17 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 33 | Down: 45 | New: 4
Join SI Premium – FREE
Cowen initiates coverage on Acadia Pharmaceuticals (NASDAQ: ACAD) with a Outperform.
For an analyst ratings summary and ratings history on Acadia Pharmaceuticals click here. For more ratings news on Acadia Pharmaceuticals click here.
Shares of Acadia Pharmaceuticals closed at $6.19 yesterday.
For an analyst ratings summary and ratings history on Acadia Pharmaceuticals click here. For more ratings news on Acadia Pharmaceuticals click here.
Shares of Acadia Pharmaceuticals closed at $6.19 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Acadia Pharmaceuticals (ACAD) PT Raised to $37 at RBC Capital on 'Strong Sales'
- TD Cowen Starts CECO Environmental Corp (CECO) at Buy
- Acadia Pharmaceuticals (ACAD) PT Raised to $25 at Oppenheimer
Create E-mail Alert Related Categories
New CoverageRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
